These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10024 related articles for article (PubMed ID: 1644665)

  • 1. Differential expression of vinculin between weakly and highly metastatic B16-melanoma cell lines.
    Sadano H; Inoue M; Taniguchi S
    Jpn J Cancer Res; 1992 Jun; 83(6):625-30. PubMed ID: 1644665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells.
    Ramos DM; Berston ED; Kramer RH
    Cancer Res; 1990 Feb; 50(3):728-34. PubMed ID: 2153445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thymosin beta4 in tumor metastasis and angiogenesis.
    Cha HJ; Jeong MJ; Kleinman HK
    J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A variant actin (beta m) reduces metastasis of mouse B16 melanoma.
    Shimokawa-Kuroki R; Sadano H; Taniguchi S
    Int J Cancer; 1994 Mar; 56(5):689-97. PubMed ID: 8314346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular localization and biochemical function of variant beta-actin, which inhibits metastasis of B16 melanoma.
    Sadano H; Shimokawa-Kuroki R; Taniguchi S
    Jpn J Cancer Res; 1994 Jul; 85(7):735-43. PubMed ID: 8071115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
    Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
    Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
    Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
    Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of a third actin accompanying malignant progression in mouse B16 melanoma cells.
    Taniguchi S; Sadano H; Kakunaga T; Baba T
    Jpn J Cancer Res; 1989 Jan; 80(1):31-40. PubMed ID: 2496056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells.
    Klemke M; Rafael MT; Wabnitz GH; Weschenfelder T; Konstandin MH; Garbi N; Autschbach F; Hartschuh W; Samstag Y
    Int J Cancer; 2007 Jun; 120(12):2590-9. PubMed ID: 17290393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparison between mouse B16 and human melanoma cell lines of the expression of ICAM-1 induced by cytokines and/or hyperthermia.
    Nakayama J; Guan XC; Nakashima M; Mashino T; Hori Y
    J Dermatol; 1997 Jun; 24(6):351-60. PubMed ID: 9241963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mofarotene-induced inhibition of melanoma cell motility by increasing vinculin-containing focal contacts.
    Helige C; Hofmann-Wellenhof R; Fink-Puches R; Smolle J
    Melanoma Res; 2004 Dec; 14(6):547-54. PubMed ID: 15577329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide.
    Ishiguro T; Naito M; Hanaoka K; Nagawa H; Muto T; Tsuruo T
    Clin Exp Metastasis; 1998 Feb; 16(2):179-83. PubMed ID: 9514099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical analysis of metastasis-related Ax actin in B16 mouse melanoma cells after chemical reversional modulation and of tumor progression-related A' actin in the ontogeny of human malignant melanoma.
    Sasase A; Mishima Y; Ichihashi M; Taniguchi S
    Pigment Cell Res; 1989; 2(6):493-501. PubMed ID: 2513567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
    Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
    Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
    Herd ZL
    Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly identified type of beta actin reduces invasiveness of mouse B16-melanoma.
    Sadano H; Taniguchi S; Baba T
    FEBS Lett; 1990 Oct; 271(1-2):23-7. PubMed ID: 2226807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
    Nicolson GL; Inoue T; Van Pelt CS; Cavanaugh PG
    Cancer Res; 1990 Feb; 50(3):515-20. PubMed ID: 2297694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells.
    Beninati S; Abbruzzese A; Cardinali M
    Int J Cancer; 1993 Mar; 53(5):792-7. PubMed ID: 8095490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant.
    Nabi IR; Raz A
    Cancer Res; 1988 Mar; 48(5):1258-64. PubMed ID: 3342405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 502.